DeepHealth's AI-powered informatics portfolio features the newly introduced Diagnostic Suite™ and TechLive™1, integrated ...

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control ...

DeepHealth has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population ...

RadNet (NASDAQ:RDNT – Free Report) had its target price hoisted by Truist Financial from $80.00 to $94.00 in a research note ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.25, ...

RadNet, Inc. RDNT yesterday announced that its wholly-owned subsidiary, DeepHealth, Inc., has partnered with artificial ...

SmartMammo™'s AI algorithm now FDA cleared with GE HealthCare's Senographe Pristina™, expanding access to enhanced cancer ...

Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet ...

SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection.The clearance ...

鉴于最近的发展，Truist Securities已经修订了RadNet 2024年至2026年的调整后EBITDA估计。新的估计为2024年$280.4百万，高于先前的$274.0百万估计。2025年和2026年的估计分别上调至$308.0百万和$336.0百万，高于先前的$300.0百万和$325.0百万预测。

4 analysts have expressed a variety of opinions on RadNet (NASDAQ:RDNT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of ...